Get started
Lipella Pharmaceuticals Inc.Lipella Pharmaceuticals Inc.Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

LIPO chart


Full chart

LIPO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.16 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.50 USD
Net income (FY)
‪−4.62 M‬ USD
Revenue (FY)
‪449.62 K‬ USD
Shares float
‪853.80 K‬
Beta (1Y)
−1.18

Employees


Employees (FY)
7
Change (1Y)
0
Revenue / Employee (1Y)
‪64.23 K‬ USD
Net income / Employee (1Y)
‪−659.85 K‬ USD

About Lipella Pharmaceuticals Inc.


Sector
Health Technology
CEO
Jonathan Kaufman
Headquarters
Pittsburgh
Website
lipella.com
Founded
2005
FIGI
BBG002GP9137
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LIPO news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LIPO is 2.61 USD — it has increased by 1.56% in the past 24 hours. Watch Lipella Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lipella Pharmaceuticals Inc. stocks are traded under the ticker LIPO.
LIPO stock has risen by 1.16% compared to the previous week, the month change is a 4.82% rise, over the last year Lipella Pharmaceuticals Inc. has showed a −67.38% decrease.
We've gathered analysts' opinions on Lipella Pharmaceuticals Inc. future price: according to them, LIPO price has a max estimate of 10.00 USD and a min estimate of 10.00 USD. Watch LIPO chart and read a more detailed Lipella Pharmaceuticals Inc. stock forecast: see what analysts think of Lipella Pharmaceuticals Inc. and suggest that you do with its stocks.
LIPO reached its all-time high on Dec 20, 2022 with the price of 61.76 USD, and its all-time low was 2.21 USD and was reached on Nov 15, 2024. View more price dynamics on LIPO chart.
See other stocks reaching their highest and lowest prices.
LIPO stock is 7.39% volatile and has beta coefficient of −1.18. Track Lipella Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Lipella Pharmaceuticals Inc. there?
Today Lipella Pharmaceuticals Inc. has the market capitalization of ‪3.16 M‬, it has decreased by −8.61% over the last week.
Yes, you can track Lipella Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Lipella Pharmaceuticals Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
LIPO earnings for the last quarter are −10.33 USD per share, whereas the estimation was −10.33 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −2.43 USD per share. See more details about Lipella Pharmaceuticals Inc. earnings.
LIPO net income for the last quarter is ‪−1.44 M‬ USD, while the quarter before that showed ‪−938.15 K‬ USD of net income which accounts for −53.99% change. Track more Lipella Pharmaceuticals Inc. financial stats to get the full picture.
No, LIPO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 7.00 employees. See our rating of the largest employees — is Lipella Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lipella Pharmaceuticals Inc. EBITDA is ‪−4.36 M‬ USD, and current EBITDA margin is ‪−1.06 K‬%. See more stats in Lipella Pharmaceuticals Inc. financial statements.
Like other stocks, LIPO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lipella Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lipella Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lipella Pharmaceuticals Inc. stock shows the sell signal. See more of Lipella Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.